Heena Sharma Blog

  TCL might be a new name in India, but this Chinese electronics maker is well recognised globally for its feature-rich and competitively-priced smart televisions. Expanding its product portfolio in India, the company recently launched its Android 11 TV platform based smart QLED TVs. Leading the pack are the TCL C725 QLED TV models with screen size of up to 65-inch, quantum LED display tech supported by high dynamic range formats (Dolby Vision, HDR10+, HDR, HLG), Onkyo sound system powered by Dolby Atmos, and wide input and connectivity options. Besides, it is one of the few smart televisions in the market that come with USB-powered plug-and-play webcam (mics integrated) for video calls and meeting over Google Duo. On paper, the TCL C725 QLED TV seems to be a wholesome package. But is it worth spending Rs 72,990 over for a 55-inch model (review unit)? Let’s find out: Design The TCL C725 QLED TV boasts a bezel-less front profile for a distraction-free viewing experience. Its 55...

  India's rising output of Covid-19 vaccines and the inoculation of more than half its adult population with at least one dose are raising hopes the country will return as an exporter within months, ramping up from early next year. After donating or selling 66 million doses to nearly 100 countries, India barred exports in the middle of April to focus on domestic immunisation as infections exploded, upsetting the inoculation plans of many African and South Asian countries. India's daily vaccinations surpassed 10 million doses on Friday, with national vaccine production more than doubling since April and set to rise again in the coming weeks. New production lines have been set up, a vaccine developed by Cadila Healthcare won recent approval, and commercial production of Russia's Sputnik V is starting in India. The Serum Institute of India (SII), the world's biggest vaccine maker, is now producing about 150 million doses a month of its version of the AstraZeneca sho...

  The risk of developing adverse events such as blood clots is considerably higher after infection with the SARS-CoV-2 virus than after immunisation with Pfizer and AstraZeneca COVID-19 vaccines , according to a large UK study published in the British Medical Journal (BMJ) on Friday. The team led by researchers at the University of Oxford in the UK conducted the study on thrombocytopenia -- a condition with low platelet counts -- and thromboembolic events or blood clots following COVID-19 vaccination with Oxford-AstraZeneca and Pfizer-BioNTech preventives. Some of these events have led to restricted use of the Oxford-AstraZeneca vaccine, known as Covishield in India, in a number of countries. The researchers compared rates of adverse events after vaccination with rates of the same events after a positive SARS-CoV-2 test result using data from over 29 million people in the UK who received the first dose of either of the two vaccines. Read More

  Odisha on Thursday reported 849 new COVID-19 cases during the last 24 hours, as per a release by the state government. 721 patients have recovered, while 66 people succumbed to the infection during the same time duration. The total number of active cases in the state stands at 8,288 and total fatalities due to the infection are 7,628. 9,88,090 people have recovered from the infection, the release further said. A total of 1,77,37,972 samples have been tested so far in the state, out of which 10,04,059 have returned positive. Read More

  India reported 37,593 new cases of Covid-19 in the last 24 hours with Kerala contributing to a majority of 24,296 fresh infections. As per the Union Health Ministry on Wednesday, 648 new fatalities pushed the cumulative toll to 4,35,758. The total caseload in the country climbed to 3,25,12,366 including 3,22,327 active cases. Active cases now account for less than 1 per cent of the total cases and is currently at 0.99 per cent. Cumulative recoveries rose to 3,17,54,281 after 34,169 fresh recoveries in the last 24 hours. With this, the recovery rate has gone up to 97.67 per cent. Read More

  The Indian Space Research Organisation has come out with an 'Announcement of Opportunity" (AO), seeking proposals towards scientific analysis and utilisation of data from all experiments of the Chandrayaan-2 orbiter. According to ISRO, the data from Chandrayaan-1 had been extensively used by Indian researchers to understand lunar morphology, surface age determination and composition of the lunar surface, studies on the possible presence of magmatic as well as exogenic water. "These studies have provided enhanced thoughtful views regarding lunar evolutionary processes", the Bengaluru-headquartered space agency said. "Such studies from Chandrayaan-1 have considerably expanded Indian lunar science community". To further strengthen the Indian research community for lunar science studies, Chandrayaan-2 orbiter payloads data are made available to public and scientific proposals are solicited for scientific analysis, it said. Chandrayaan-2 orbiter is cur...

  With the addition of 196 new cases of coronavirus , the infection count in Maharashtra's Thane district has gone up to 5,49,596, an official said on Monday. These new cases were reported on Sunday, he said. The virus also claimed the lives of five more people, which pushed the death toll in the district to 11,244, he said, adding that the COVID-19 mortality rate in Thane stood at 2.04 per cent. In neighbouring Palghar district, the COVID-19 case count has gone up to 1,34,236, while the death toll has reached 3,277, another official said. Read More